Valsalva maneuver (MVM)	conventional treatment group (NVM)	positive rate of HUTT (Head-up tilt testing (HUTT) after 30 days	17005	17118	After 30 days treatment, the positive rate of HUTT was 9.7% in MVM group and 79.4% in NVM group (P<0.01, Fig 3A).
Valsalva maneuver (MVM)	conventional treatment group (NVM)	Incidence of recurrent syncope after 12 months	706	898	Incidence of recurrent syncope after 12 months (6.5% vs. 41.2%, P<0.01) and rate of positive HUTT after 30 days (9.7% vs.79.4%, P<0.01) were significantly lower in MVM group than in NVM group.
